Steven Lo, Zosano Pharma CEO
After filing for bankruptcy, rejected migraine drug developer Zosano’s value more than halved
The devastations of the public markets and the repeated rejections handed down by the FDA have added up to a dim future for Zosano Pharma …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
